Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Covington
Federal Trade Commission
US Department of Justice
Dow
UBS
Teva
McKesson
Cerilliant

Generated: September 20, 2018

DrugPatentWatch Database Preview

MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45% Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Mannitol 15% W/ Dextrose 5% In Sodium Chloride 0.45% patents expire, and what generic alternatives are available?

Mannitol 15% W/ Dextrose 5% In Sodium Chloride 0.45% is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45% is mannitol. There are eighteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the mannitol profile page.

Summary for MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%
Drug patent expirations by year for MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%
Medical Subject Heading (MeSH) Categories for MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%

US Patents and Regulatory Information for MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45% mannitol INJECTABLE;INJECTION 016080-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Covington
Federal Trade Commission
US Department of Justice
Dow
UBS
Teva
McKesson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.